Art. 4 Regulation (EU) 2024/2699

Information exchange with the Coordination Group and its EHT Subgroup and JCA Subgroup

In forcesince 18 Oct 2024
1.

Once the HTA secretariat receives the information from the European Medicines Agency pursuant to Article 2, it shall make that information available as appropriate to the EHT Subgroup or to the Coordination Group, or both, for further analysis in the preparation of the reports on emerging health technologies referred to in Article 22 of Regulation (EU) 2021/2282 and for the preparation and amendment of the annual work programme of the Coordination Group.

The EHT Subgroup may, via the HTA secretariat, consult the European Medicines Agency in the context of preparing the reports on emerging health technologies referred to in Article 22 of Regulation (EU) 2021/2282.

2.

Once the HTA secretariat receives the information from the European Medicines Agency pursuant to Article 3, it shall make that information available for further analysis in the preparation of the recommendation referred to in Article 7(4) of Regulation (EU) 2021/2282 to the following:

(a)

the Coordination Group;

(b)

the EHT Subgroup or the JCA Subgroup, based on the decision of the Coordination Group; or

(c)

the Coordination Group and the EHT Subgroup or the JCA Subgroup, based on the decision of the Coordination Group.